Skip to content

C3is Inc.: 20-F filed 2026-04-22

What C3is Inc. reported in its annual report (foreign private issuer) filed 2026-04-22 (fiscal FY 2025): 35 published measures, 96 facts as tagged in accession 0001193125-26-170448.

This filing

Form
20-F (annual report (foreign private issuer))
Filed
2026-04-22
Fiscal period
fiscal FY 2025
Accession
0001193125-26-170448 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All C3is Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2025-12-3198,486,630USD
At 2024-12-31100,489,163USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2025-12-313,387,016USD
At 2024-12-3129,127,908USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2025-12-3195,099,614USD
At 2024-12-3171,361,255USD
At 2023-12-3155,543,849USD
At 2022-12-3138,894,205USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2025-12-31616,640USD
At 2024-12-314,640,343USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2025-01-01 to 2025-12-3110,473,210USD365
2024-01-01 to 2024-12-31-2,748,367USD366
2023-01-01 to 2023-12-319,291,912USD365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2025-01-01 to 2025-12-314,001,822USD365
2024-01-01 to 2024-12-3124,976,137USD366
2023-01-01 to 2023-12-315,639,144USD365

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2025-01-01 to 2025-12-31161,900USD365
2024-01-01 to 2024-12-311,623,125USD366
2023-01-01 to 2023-12-314,300,000USD365

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2025-01-01 to 2025-12-3134,755,612USD365
2024-01-01 to 2024-12-3142,296,101USD366
2023-01-01 to 2023-12-3128,738,982USD365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2025-01-01 to 2025-12-31-1,488,332USD365
2024-01-01 to 2024-12-31-19,670,747USD366
2023-01-01 to 2023-12-317,482,594USD365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2025-01-01 to 2025-12-31-6,537,193USD365
2024-01-01 to 2024-12-31-1,360,335USD366
2023-01-01 to 2023-12-31-12,426,450USD365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2025-12-314,485,845USD
At 2024-12-31257,052USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2025-01-01 to 2025-12-3189,967shares365
2024-01-01 to 2024-12-3123,007shares366
2023-01-01 to 2023-12-31181shares365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2025-01-01 to 2025-12-31350,055shares365
2024-01-01 to 2024-12-3123,007shares366
2023-01-01 to 2023-12-31487shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2025-01-01 to 2025-12-3146.5USD/shares365
2024-01-01 to 2024-12-31-351.58USD/shares366
2023-01-01 to 2023-12-3147,133.25USD/shares365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2025-01-01 to 2025-12-313.98USD/shares365
2024-01-01 to 2024-12-31-351.58USD/shares366
2023-01-01 to 2023-12-3118,911.99USD/shares365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2025-12-3177,647,921USD
At 2024-12-3184,149,805USD
At 2023-12-3175,161,431USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2025-01-01 to 2025-12-31375,224USD365
2024-01-01 to 2024-12-31337,855USD366
2023-01-01 to 2023-12-3137,638USD365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-12-311,364,430USD365
2024-01-01 to 2024-12-3110,061,966USD366
2023-01-01 to 2023-12-3110,427,961USD365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2025-12-3120,838,709USD
At 2024-12-3116,339,358USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2025-12-313,357,855USD
At 2024-12-3118,690,874USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2025-01-01 to 2025-12-3133,391,182USD365
2024-01-01 to 2024-12-3132,234,135USD366
2023-01-01 to 2023-12-3118,311,021USD365

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2025-12-311,312,062USD
At 2024-12-31884,148USD

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2025-12-31659,668shares
At 2024-12-3135,324shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2025-12-31616,640USD
At 2024-12-314,640,343USD
At 2023-12-31695,288USD
At 2022-12-310USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2025-12-3190,601,172USD
At 2024-12-3171,097,850USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2025-12-3194,990,150USD
At 2024-12-3194,990,150USD
At 2023-12-3179,824,125USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2025-12-3117,342,229USD
At 2024-12-3110,840,345USD
At 2023-12-314,662,694USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2025-12-31911,201USD
At 2024-12-311,272,095USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

PeriodValueUnitDays
At 2025-12-3115,378USD
At 2024-12-3121,951USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2025-01-01 to 2025-12-314,183,254USD365
2024-01-01 to 2024-12-31-8,088,867USD366
2023-01-01 to 2023-12-318,531,118USD365

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2025-01-01 to 2025-12-316,501,884USD365
2024-01-01 to 2024-12-316,177,651USD366
2023-01-01 to 2023-12-314,104,720USD365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2025-01-01 to 2025-12-319,108,780USD365
2024-01-01 to 2024-12-31-12,810,333USD366
2023-01-01 to 2023-12-31-1,136,049USD365

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2025-01-01 to 2025-12-311,190,000USD365
2024-01-01 to 2024-12-313,000,000USD366
2023-01-01 to 2023-12-310USD365

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-12-311,447,445USD365
2024-01-01 to 2024-12-31-7,628,055USD366
2023-01-01 to 2023-12-319,768,670USD365

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2025-01-01 to 2025-12-31427,914USD365
2024-01-01 to 2024-12-31194,879USD366
2023-01-01 to 2023-12-31523,624USD365

Inspect the source

Entity
C3is Inc. / CIK 0001951067
Captured
2026-09-21T17:36:04.952Z
SEC response SHA-256
da78fecd21511a9fb874f191811207b146280ddcad5263929138cc60c5fd2ff9

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001951067.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))